Archives

img-01

Quick Asia Regulatory Updates (February 2026)

On January 15, Singapore’s Health Sciences Authority (HSA) and the Indonesian Food and Drug Authority signed a Memorandum of Understanding (MoU) to improve regulatory cooperation. Both agencies have obtained the World Health Organization (WHO) Listed Authority status, which confirms that they have met... Read More

img-01

Clinical Trials in Asia Gain Momentum

Approximately 50% of global clinical trials are conducted in the Asia Pacific region today. The clinical trial landscape of Asia has been expanding beyond China in recent years. Although over 60% of the clinical trials in the region were initiated in China... Read More

img-01

Singapore Initiates Health Information Bill

The Parliament of Singapore made a considerable effort towards enhancing the country’s digital health infrastructure via the introduction of the Health Information Bill (HIB) on November 5, 2025. The Health Information Bill has been widely anticipated for several years and dates back... Read More

img-01

Quick Asia Regulatory Updates (December 2025)

Singapore’s Health Sciences Authority (HSA) has officially opened its new electronic Common Technical Document (eCTD) portal for test submissions. This represents an important move towards the process of digitalizing regulatory submissions for therapeutic products. The eCTD Specification Package version 1.0 will be... Read More

img-01

Singapore’s Evolving Digital Health Regulatory Landscape

Singapore has quickly become a regional leader in digital health innovation thanks to its strong regulatory frameworks for emerging technologies, including mobile health applications, connected wearables, and AI-enabled devices. As healthcare delivery increasingly makes the transition to digital platforms over the years, the Singaporean Health Sciences... Read More